Contact
Please use this form to send email to PR contact of this press release:
Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC
TO:
Please use this form to send email to PR contact of this press release:
Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC
TO: